Receive our newsletter – data, insights and analysis delivered to you
  1. Uncategorized
  2. c-icon icon-chevron-right
September 25, 2020

Covid is taking a big bite from US tax revenues – cyberattacks on the rise

By Paul Dennis

25 September

The Covid-19 pandemic is impacting state and local tax revenues similar to any other recession.

The level of impact, however, is far higher than historical figures.

David Wessel, director of Hutchins Center on Fiscal & Monetary Policy, shared an article on how state and local tax revenues have been impacted by the Covid-19 pandemic in the US.

The impact of income tax revenues is recorded to be low as most of the employment losses are concentrated on low-wage workers.

Sales and other tax revenues, however, have fallen sharply compared to historical figures due to fall in consumption rate as more people are staying home.

Content from our partners
Africa’s last mile: Building viable vaccine supply chains
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
Patient-centric pharma logistics: How CRYOPDP delivers hope worldwide

As a result, revenues generated from taxes and fees imposed on the tourism, travel and hospitality sectors have plummeted.

Revenues of state and local governments are expected to decline by 5.5% in 2020 and 5.7% in 2021, the article added.

The fiscal aid provided by the government has helped in offsetting some of the revenue losses but state and local governments are expected to face further shortfalls forcing them to make spending cuts.

In other news, Ian Bremmer, a political scientist and author, shared an article on how cyberattacks have increased amid the pandemic.

Read more

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU